SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome
- PMID: 33724541
- PMCID: PMC8250256
- DOI: 10.1111/pai.13504
SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome
Conflict of interest statement
MTD and MG have a commercial relationship with Abingdon Health. The rest of the authors declared no conflict of interest. AFC is grateful for funding from The Medical Research Council (MC_PC_17183), the Global Challenges Research Fund (GCRF), and The Institute for Global Innovation (IGI, Project 3107) of The University of Birmingham. This study was supported by the UK National Institute for Health Research, Birmingham Biomedical Research Centres Funding scheme. Dr Barnaby Scholefield is funded by the NIHR Clinician Scientist fellowship program. The work in Prof. Max Crispin's laboratory was funded by the International AIDS Vaccine Initiative, Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery (OPP1084519 and OPP1115782), the Scripps Consortium for HIV Vaccine Development (CHAVD) (AI144462), and the University of Southampton Coronavirus Response Fund which has over 1000 donors from around the world.
Figures
Update of
-
Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome.medRxiv [Preprint]. 2020 Jun 7:2020.06.05.20123117. doi: 10.1101/2020.06.05.20123117. medRxiv. 2020. Update in: Pediatr Allergy Immunol. 2021 Jul;32(5):1125-1129. doi: 10.1111/pai.13504. PMID: 32577677 Free PMC article. Updated. Preprint.
References
-
- Health, R. C. o. P. a. C . Guidance ‐ COVID‐19 paediatric multisystem inflammatory syndrome (2020).
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
